chr3-39407646-T-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_002295.6(RPSA):​c.-8T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,581,046 control chromosomes in the GnomAD database, including 193,633 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19015 hom., cov: 32)
Exomes 𝑓: 0.49 ( 174618 hom. )

Consequence

RPSA
NM_002295.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.34
Variant links:
Genes affected
RPSA (HGNC:6502): (ribosomal protein SA) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. This gene encodes a high-affinity, non-integrin family, laminin receptor 1. This receptor has been variously called 67 kD laminin receptor, 37 kD laminin receptor precursor (37LRP) and p40 ribosome-associated protein. The amino acid sequence of laminin receptor 1 is highly conserved through evolution, suggesting a key biological function. It has been observed that the level of the laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype. Multiple copies of this gene exist, however, most of them are pseudogenes thought to have arisen from retropositional events. Two alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 3-39407646-T-C is Benign according to our data. Variant chr3-39407646-T-C is described in ClinVar as [Benign]. Clinvar id is 403395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPSANM_002295.6 linkc.-8T>C 5_prime_UTR_variant Exon 2 of 7 ENST00000301821.11 NP_002286.2 P08865A0A024R2L6
RPSANM_001304288.2 linkc.-8T>C 5_prime_UTR_variant Exon 2 of 7 NP_001291217.1 P08865A0A0C4DG17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPSAENST00000301821 linkc.-8T>C 5_prime_UTR_variant Exon 2 of 7 1 NM_002295.6 ENSP00000346067.4 P08865

Frequencies

GnomAD3 genomes
AF:
0.495
AC:
75272
AN:
151926
Hom.:
18981
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.533
Gnomad AMI
AF:
0.401
Gnomad AMR
AF:
0.469
Gnomad ASJ
AF:
0.560
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.429
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.508
Gnomad OTH
AF:
0.491
GnomAD2 exomes
AF:
0.460
AC:
107557
AN:
233646
AF XY:
0.460
show subpopulations
Gnomad AFR exome
AF:
0.524
Gnomad AMR exome
AF:
0.427
Gnomad ASJ exome
AF:
0.557
Gnomad EAS exome
AF:
0.300
Gnomad FIN exome
AF:
0.440
Gnomad NFE exome
AF:
0.506
Gnomad OTH exome
AF:
0.488
GnomAD4 exome
AF:
0.489
AC:
699472
AN:
1429002
Hom.:
174618
Cov.:
32
AF XY:
0.486
AC XY:
345893
AN XY:
712156
show subpopulations
Gnomad4 AFR exome
AF:
0.529
AC:
17548
AN:
33144
Gnomad4 AMR exome
AF:
0.431
AC:
19253
AN:
44694
Gnomad4 ASJ exome
AF:
0.562
AC:
14617
AN:
26014
Gnomad4 EAS exome
AF:
0.334
AC:
13242
AN:
39610
Gnomad4 SAS exome
AF:
0.376
AC:
32271
AN:
85906
Gnomad4 FIN exome
AF:
0.438
AC:
16654
AN:
37994
Gnomad4 NFE exome
AF:
0.505
AC:
554202
AN:
1096528
Gnomad4 Remaining exome
AF:
0.490
AC:
29241
AN:
59692
Heterozygous variant carriers
0
15828
31655
47483
63310
79138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
15852
31704
47556
63408
79260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.496
AC:
75360
AN:
152044
Hom.:
19015
Cov.:
32
AF XY:
0.489
AC XY:
36346
AN XY:
74318
show subpopulations
Gnomad4 AFR
AF:
0.533
AC:
0.533433
AN:
0.533433
Gnomad4 AMR
AF:
0.469
AC:
0.469163
AN:
0.469163
Gnomad4 ASJ
AF:
0.560
AC:
0.560012
AN:
0.560012
Gnomad4 EAS
AF:
0.330
AC:
0.330174
AN:
0.330174
Gnomad4 SAS
AF:
0.382
AC:
0.382207
AN:
0.382207
Gnomad4 FIN
AF:
0.429
AC:
0.428815
AN:
0.428815
Gnomad4 NFE
AF:
0.508
AC:
0.507854
AN:
0.507854
Gnomad4 OTH
AF:
0.490
AC:
0.490047
AN:
0.490047
Heterozygous variant carriers
0
1955
3910
5864
7819
9774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.506
Hom.:
7905
Bravo
AF:
0.498
Asia WGS
AF:
0.365
AC:
1274
AN:
3478
EpiCase
AF:
0.503
EpiControl
AF:
0.512

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial isolated congenital asplenia Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
19
DANN
Benign
0.91
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1803893; hg19: chr3-39449137; COSMIC: COSV57191604; COSMIC: COSV57191604; API